Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6479)
All Articles published online
|
Mar 14, 2011 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou HB, Wang H, Li YQ, Li SX, Wang H, Zhou DX, Tu QQ, Wang Q, Zou SS, Wu MC, Hu HP. Hepatitis B virus infection: A favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011; 17(10): 1292-1303 [PMID: 21455328 DOI: 10.3748/wjg.v17.i10.1292] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i10/1292.htm |
| Number | Citing Articles |
| 1 |
Hannes Jansson, Christina Villard, Lynn E. Nooijen, Poya Ghorbani, Joris I. Erdmann, Ernesto Sparrelid. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology 2023; 49(4): 688 doi: 10.1016/j.ejso.2023.01.006
|
| 2 |
Seogsong Jeong, Qingbao Cheng, Lifeng Huang, Jian Wang, Meng Sha, Ying Tong, Lei Xia, Longzhi Han, Zhifeng Xi, Jianjun Zhang, Xiaoni Kong, Jinyang Gu, Qiang Xia. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3464-5
|
| 3 |
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
|
| 4 |
Masaki Kaibori, Kengo Yoshii, Kosuke Kashiwabara, Takashi Kokudo, Kiyoshi Hasegawa, Namiki Izumi, Takamichi Murakami, Masatoshi Kudo, Shuichiro Shiina, Michiie Sakamoto, Osamu Nakashima, Yutaka Matsuyama, Susumu Eguchi, Tatsuya Yamashita, Tadatoshi Takayama, Norihiro Kokudo, Shoji Kubo. Impact of hepatitis C virus on survival in patients undergoing resection of intrahepatic cholangiocarcinoma: Report of a Japanese nationwide survey. Hepatology Research 2021; 51(8): 890 doi: 10.1111/hepr.13676
|
| 5 |
Ruo-Fan Sheng, Meng-Su Zeng, Sheng-Xiang Rao, Yuan Ji, Ling-Li Chen. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study. Clinical Imaging 2014; 38(3): 265 doi: 10.1016/j.clinimag.2013.12.022
|
| 6 |
Wen‐Qiang Wang, Guang‐Yuan Xu, Jian Li, Bin‐Yong Liang, Jiang Li, Mei‐Long Lin, Xiao‐Ping Chen, Er‐Lei Zhang, Zhi‐Yong Huang. HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma. Cancer Medicine 2023; 12(8): 9627 doi: 10.1002/cam4.5740
|
| 7 |
Qi Li, Chen Chen, Jingbo Su, Yinghe Qiu, Hong Wu, Tianqiang Song, Xianhai Mao, Yu He, Zhangjun Cheng, Jingdong Li, Wenlong Zhai, Dong Zhang, Zhimin Geng, Zhaohui Tang. Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09448-w
|
| 8 |
Shun-ichi Ariizumi, Masakazu Yamamoto. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis. Surgery Today 2015; 45(6): 682 doi: 10.1007/s00595-014-1031-0
|
| 9 |
Z.‐F. Wu, N. Yang, D.‐Y. Li, H.‐B. Zhang, G.‐S. Yang. Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours. Journal of Viral Hepatitis 2013; 20(5): 306 doi: 10.1111/jvh.12005
|
| 10 |
Changzheng Wang, Shujie Pang, Hui Si-Ma, Ning Yang, Haibin Zhang, Yong Fu, Guangshun Yang. Specific risk factors contributing to early and late recurrences of intrahepatic cholangiocarcinoma after curative resection. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-018-1540-1
|
| 11 |
Qun-Xiong Pan, Zi-Jian Su, Jian-Hua Zhang, Chong-Ren Wang, Shao-Ying Ke. Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma. Molecular and Clinical Oncology 2017; 6(4): 566 doi: 10.3892/mco.2017.1166
|
| 12 |
Zeyu Zhang, Yufan Zhou, Kuan Hu, Dong Wang, Zhiming Wang, Yun Huang. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06781-w
|
| 13 |
Seogsong Jeong, Ying Tong, Meng Sha, Jinyang Gu, Qiang Xia. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget 2017; 8(10): 17292 doi: 10.18632/oncotarget.14079
|
| 14 |
Agostino Maria De Rose, Alessandro Cucchetti, Gennaro Clemente, Francesco Ardito, Ivo Giovannini, Giorgio Ercolani, Felice Giuliante, Antonio Daniele Pinna, Gennaro Nuzzo. Prognostic Significance of Tumor Doubling Time in Mass-Forming Type Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2013; 17(4): 739 doi: 10.1007/s11605-012-2129-6
|
| 15 |
Zhen-Feng Wu, Xiao-Yu Wu, Nan Zhu, Zhe Xu, Wei-Su Li, Hai-Bin Zhang, Ning Yang, Xue-Quan Yao, Fu-Kun Liu, Guang-Shun Yang. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2015; 21(3): 935-943 doi: 10.3748/wjg.v21.i3.935
|
| 16 |
Seogsong Jeong, Lei Gao, Ying Tong, Lei Xia, Ning Xu, Meng Sha, Jianjun Zhang, Xiaoni Kong, Jinyang Gu, Qiang Xia. Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/6543423
|
| 17 |
Xiao-Bo Xu, Chen Hu, Han-Jin Yang, Shu-Sen Zheng. Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection. Hepatobiliary & Pancreatic Diseases International 2022; 21(5): 472 doi: 10.1016/j.hbpd.2022.07.010
|
| 18 |
Zhizhen Li, Qingxiang Gao, Yingjun Wu, Xiaoming Ma, Fangyan Wu, Siyu Luan, Sunrui Chen, Siyuan Shao, Yang Shen, Ding Zhang, Feiling Feng, Lei Yuan, Shaohua Wei. HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma. Hepatology Communications 2024; 8(1) doi: 10.1097/HC9.0000000000000360
|
| 19 |
Lei Yuan, Xianwu Luo, Xinyuan Lu, Bin Huang, Quanyu Cai. Liver resection for intrahepatic cholangiocarcinoma in AJCC-stage IV: An evaluation of the survival benefit and prognostic accuracy of current AJCC staging system on N and M classification. Oncology Reports 2016; 36(5): 2663 doi: 10.3892/or.2016.5103
|
| 20 |
Meng Sha, Seogsong Jeong, Xin Wang, Ying Tong, Jie Cao, Han-Yong Sun, Lei Xia, Ning Xu, Zhi-Feng Xi, Jian-Jun Zhang, Xiao-Ni Kong, Qiang Xia. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5420-z
|
| 21 |
Kutay Saglam, Yusuf Murat Bag, Zafer Bilen, Burak Isik, Cemalettin Aydin, Sezai Yilmaz. Results of Intrahepatic Cholangiocarcinoma Resections: a Single-Center Analysis. Journal of Gastrointestinal Cancer 2022; 53(4): 1034 doi: 10.1007/s12029-021-00781-0
|
| 22 |
Guifang Shang, Alice Richardson, Michelle E. Gahan, Simon Easteal, Stephen Ohms, Brett A. Lidbury. Predicting the presence of hepatitis B virus surface antigen in Chinese patients by pathology data mining. Journal of Medical Virology 2013; 85(8): 1334 doi: 10.1002/jmv.23609
|
| 23 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 605 doi: 10.1007/978-3-319-26956-6_31
|
| 24 |
Takahiro Uenishi, Hiroaki Nagano, Shigeru Marubashi, Michihiro Hayashi, Fumitoshi Hirokawa, Masaki Kaibori, Kousuke Matsui, Shoji Kubo. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: A multicenter analysis by Osaka Hepatic Surgery Study Group. Journal of Surgical Oncology 2014; 110(2): 176 doi: 10.1002/jso.23611
|
| 25 |
Wei Yu, Chunxiu Hu, Yongjie Shui, Kui Wu, Lili Zhang, Ying Chen, Chao Li, Jing Xu, Qichun Wei. Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6328-3
|
| 26 |
Tianzhen Wang, Yinji Jin, Ran Zhao, Yiqi Wu, Yuhua Zhang, Di Wu, Dan Kong, Xiaoming Jin, Fengmin Zhang. High load hepatitis B virus replication inhibits hepatocellular carcinoma cell metastasis through regulation of epithelial–mesenchymal transition. International Journal of Infectious Diseases 2014; 20: 37 doi: 10.1016/j.ijid.2013.11.015
|
| 27 |
Jianbo Huang, Xiangyu Wang, Ying Zhu, Zheng Wang, Jianhua Li, Da Xu, Shenghao Wang, Tian‐En Li, Lu Lu. Specific prognostic factors in hepatitis B virus‐related and non‐hepatitis B virus–related intrahepatic cholangiocarcinoma after macroscopic curative resection. Journal of Surgical Oncology 2019; 119(1): 40 doi: 10.1002/jso.25303
|
| 28 |
Kwang Min Kim, Ji Eun Na, Sang Goon Shim, Dong Hyun Sinn. Comparison of ICC patients with hepatitis B infection to those with no major risk factors for HCC. HPB 2021; 23(6): 945 doi: 10.1016/j.hpb.2020.10.011
|
| 29 |
Yang Xin-wei, Li Liang, Hou Guo-jun, Yan Xin-zhou, Xu Qin-guo, Chen Lei, Zhang Bao-hua, Shen Feng. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Oncotarget 2017; 8(5): 7710 doi: 10.18632/oncotarget.13846
|
| 30 |
Rui-qing Liu, Shu-jing Shen, Xiu-feng Hu, Jie Liu, Li-juan Chen, Xing-ya Li. Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors. Cancer Cell International 2013; 13(1): 99 doi: 10.1186/1475-2867-13-99
|
| 31 |
Xiaoli Huang, Dan Yu, Xintao Gu, Jiansun Li, Jiaqi Chen, Yuanqiang Zou, Jinyuan Liao. A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47108-6
|
| 32 |
Shanshan Zou, Jiarui Li, Huabang Zhou, Christian Frech, Xiaolan Jiang, Jeffrey S. C. Chu, Xinyin Zhao, Yuqiong Li, Qiaomei Li, Hui Wang, Jingyi Hu, Guanyi Kong, Mengchao Wu, Chuanfan Ding, Nansheng Chen, Heping Hu. Mutational landscape of intrahepatic cholangiocarcinoma. Nature Communications 2014; 5(1) doi: 10.1038/ncomms6696
|
| 33 |
Xianwu Luo, Lei Yuan, Yi Wang, Ruiliang Ge, Yanfu Sun, Gongtian Wei. Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study. Journal of Gastrointestinal Surgery 2014; 18(3): 562 doi: 10.1007/s11605-013-2447-3
|
| 34 |
Chul‐Soo Ahn, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Sung‐Gyu Lee. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma. ANZ Journal of Surgery 2018; 88(3): 212 doi: 10.1111/ans.13753
|
| 35 |
Tingfeng Huang, Hongzhi Liu, Zhaowang Lin, Jie Kong, Kongying Lin, Zhipeng Lin, Yifan Chen, Qizhu Lin, Weiping Zhou, Jingdong Li, Jiang-Tao Li, Yongyi Zeng. Preoperative prediction of intrahepatic cholangiocarcinoma lymph node metastasis by means of machine learning: a multicenter study in China. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10025-4
|
| 36 |
Hiroya Iida, Masaki Kaibori, Shogo Tanaka, Shigekazu Takemura, Hiroshi Wada, Fumitoshi Hirokawa, Takuya Nakai, Michihiro Hayashi, Hidetoshi Eguchi, Shoji Kubo. Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus‐Related Intrahepatic Cholangiocarcinoma. World Journal of Surgery 2017; 41(4): 1082 doi: 10.1007/s00268-016-3843-0
|
| 37 |
Mathew M. Augustine, Yuman Fong. Epidemiology and Risk Factors of Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 2014; 23(2): 171 doi: 10.1016/j.soc.2013.10.001
|
| 38 |
Laurent Sulpice, Michel Rayar, Eveline Boucher, Fabienne Pele, Marc Pracht, Bernard Meunier, Karim Boudjema. Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resection. Journal of Surgical Research 2013; 180(1): 56 doi: 10.1016/j.jss.2012.10.051
|
| 39 |
Meric A. Altinoz, Aysel Ozpinar, Alp Ozpinar, Emily Hacker, İlhan Elmaci. Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?. Clinical and Experimental Pharmacology and Physiology 2019; 46(8): 694 doi: 10.1111/1440-1681.13096
|
| 40 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
|
| 41 |
Yun-Jau Chang, Yao-Jen Chang, Li-Ju Chen. Prognostic factors in patients with intrahepatic cholangiocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70124-z
|
| 42 |
Zheng Wang, Yuan-Yuan Sheng, Qiong-Zhu Dong, Lun-Xiu Qin. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis. World Journal of Gastroenterology 2016; 22(10): 3038-3051 doi: 10.3748/wjg.v22.i10.3038
|
| 43 |
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?. World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
|